Traded Jul 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Jun 10, 2026 · Filed Jun 13, 2026
The CEO of Alignment Healthcare sold $1.47M of Alignment Healthcare shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,472,350
Shares × reported transaction price
41 days after results of Apr 30, 2026, 50 days before results of Jul 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +7.6% | −1.4% | +9.0% |
| 30 days | +5.8% | 0.0% | +5.8% |
| 90 days | −34.6% | +0.8% | −35.4% |
Past results only. Not a forecast.
Traded Jul 1 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Joseph S Konowiecki (EVP, Corporate Affairs) sold ~$600K of Alignment Healthcare, Inc.
Scheduled in advanceJoseph S Konowiecki (EVP, Corporate Affairs) sold ~$575K of Alignment Healthcare, Inc.
Scheduled in advance